520 related articles for article (PubMed ID: 27111654)
1. Albumin Carriers for Cancer Theranostics: A Conventional Platform with New Promise.
Chen Q; Liu Z
Adv Mater; 2016 Dec; 28(47):10557-10566. PubMed ID: 27111654
[TBL] [Abstract][Full Text] [Related]
2. 2D Nanomaterials for Cancer Theranostic Applications.
Cheng L; Wang X; Gong F; Liu T; Liu Z
Adv Mater; 2020 Apr; 32(13):e1902333. PubMed ID: 31353752
[TBL] [Abstract][Full Text] [Related]
3. Oligonucleotide-based theranostic nanoparticles in cancer therapy.
Shahbazi R; Ozpolat B; Ulubayram K
Nanomedicine (Lond); 2016 May; 11(10):1287-308. PubMed ID: 27102380
[TBL] [Abstract][Full Text] [Related]
4. Albumin Nanovectors in Cancer Therapy and Imaging.
Parodi A; Miao J; Soond SM; Rudzińska M; Zamyatnin AA
Biomolecules; 2019 Jun; 9(6):. PubMed ID: 31195727
[TBL] [Abstract][Full Text] [Related]
5. Conjugated Polymer Nanoparticles for Tumor Theranostics.
Li T; Wu M; Wei Q; Xu D; He X; Wang J; Wu J; Chen L
Biomacromolecules; 2023 May; 24(5):1943-1979. PubMed ID: 37083404
[TBL] [Abstract][Full Text] [Related]
6. Calcium phosphate nanocarriers for drug delivery to tumors: imaging, therapy and theranostics.
Huang D; He B; Mi P
Biomater Sci; 2019 Oct; 7(10):3942-3960. PubMed ID: 31414096
[TBL] [Abstract][Full Text] [Related]
7. Theranostics based on AIEgens.
Wang D; Lee MMS; Xu W; Kwok RTK; Lam JWY; Tang BZ
Theranostics; 2018; 8(18):4925-4956. PubMed ID: 30429878
[TBL] [Abstract][Full Text] [Related]
8. Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
Pitek AS; Hu H; Shukla S; Steinmetz NF
ACS Appl Mater Interfaces; 2018 Nov; 10(46):39468-39477. PubMed ID: 30403330
[TBL] [Abstract][Full Text] [Related]
9. Molybdenum disulfide-based hyaluronic acid-guided multifunctional theranostic nanoplatform for magnetic resonance imaging and synergetic chemo-photothermal therapy.
Liu J; Zheng J; Nie H; Zhang D; Cao D; Xing Z; Li B; Jia L
J Colloid Interface Sci; 2019 Jul; 548():131-144. PubMed ID: 30991180
[TBL] [Abstract][Full Text] [Related]
10. Polyester micelles for drug delivery and cancer theranostics: Current achievements, progresses and future perspectives.
Yi Y; Lin G; Chen S; Liu J; Zhang H; Mi P
Mater Sci Eng C Mater Biol Appl; 2018 Feb; 83():218-232. PubMed ID: 29208282
[TBL] [Abstract][Full Text] [Related]
11. Recent Progress of Nanoscale Metal-Organic Frameworks in Cancer Theranostics and the Challenges of Their Clinical Application.
Sun W; Li S; Tang G; Luo Y; Ma S; Sun S; Ren J; Gong Y; Xie C
Int J Nanomedicine; 2019; 14():10195-10207. PubMed ID: 32099352
[TBL] [Abstract][Full Text] [Related]
12. Semiconducting Perylene Diimide Nanostructure: Multifunctional Phototheranostic Nanoplatform.
Yang Z; Chen X
Acc Chem Res; 2019 May; 52(5):1245-1254. PubMed ID: 30977625
[TBL] [Abstract][Full Text] [Related]
13. [Supramolecular Agents for Theranostics].
Deyev SM; Lebedenko EN
Bioorg Khim; 2015; 41(5):539-52. PubMed ID: 26762091
[TBL] [Abstract][Full Text] [Related]
14. Construction of Silica-Based Micro/Nanoplatforms for Ultrasound Theranostic Biomedicine.
Zhou Y; Han X; Jing X; Chen Y
Adv Healthc Mater; 2017 Sep; 6(18):. PubMed ID: 28795530
[TBL] [Abstract][Full Text] [Related]
15. Comprehensive approach of hybrid nanoplatforms in drug delivery and theranostics to combat cancer.
Thorat ND; Townley HE; Patil RM; Tofail SAM; Bauer J
Drug Discov Today; 2020 Jul; 25(7):1245-1252. PubMed ID: 32371139
[TBL] [Abstract][Full Text] [Related]
16. Hybrid quantum dot-based theranostic nanomedicines for tumor-targeted drug delivery and cancer imaging.
Zayed DG; AbdElhamid AS; Freag MS; Elzoghby AO
Nanomedicine (Lond); 2019 Feb; 14(3):225-228. PubMed ID: 30652951
[No Abstract] [Full Text] [Related]
17. Dendrimer Architectonics to Treat Cancer and Neurodegenerative Diseases with Implications in Theranostics and Personalized Medicine.
Moorthy H; Govindaraju T
ACS Appl Bio Mater; 2021 Feb; 4(2):1115-1139. PubMed ID: 35014470
[TBL] [Abstract][Full Text] [Related]
18. Advances in Functionalized Mesoporous Silica Nanoparticles for Tumor Targeted Drug Delivery and Theranostics.
Zhang W; Liu M; Liu A; Zhai G
Curr Pharm Des; 2017; 23(23):3367-3382. PubMed ID: 27784244
[TBL] [Abstract][Full Text] [Related]
19. Glycosylated nanoplatforms: From glycosylation strategies to implications and opportunities for cancer theranostics.
Zare I; Zirak Hassan Kiadeh S; Varol A; Ören Varol T; Varol M; Sezen S; Zarepour A; Mostafavi E; Zahed Nasab S; Rahi A; Khosravi A; Zarrabi A
J Control Release; 2024 Jul; 371():158-178. PubMed ID: 38782062
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional hypoxia imaging nanoparticles: multifunctional tumor imaging and related guided tumor therapy.
Liu J; Liu Z; Wu D
Int J Nanomedicine; 2019; 14():707-719. PubMed ID: 30705587
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
